Effectiveness and cost-effectiveness of 3-monthly versus 6-monthly monitoring of well-controlled type 2 diabetes patients: a pragmatic randomised controlled patient-preference equivalence trial in primary care (EFFIMODI study).

P.R. Wermeling; K.J. Gorter; R.K. Stellato; G.A. de Wit; J.W.J. Beulens; G.E.H.M. Rutten

Effectiveness and cost-effectiveness of 3-monthly versus 6-monthly monitoring of well-controlled type 2 diabetes patients: a pragmatic randomised controlled patient-preference equivalence trial in primary care (EFFIMODI study).

Translated title of the contribution: Effectiveness and cost-effectiveness of 3-monthly versus 6-monthly monitoring of well-controlled type 2 diabetes patients: a pragmatic randomised controlled patient-preference equivalence trial in primary care (EFFIMODI study).

P.R. Wermeling
, K.J. Gorter
, R.K. Stellato
, G.A. de Wit
, J.W.J. Beulens
, G.E.H.M. Rutten

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Effectiveness and cost-effectiveness of 3-monthly versus 6-monthly monitoring of well-controlled type 2 diabetes patients: a pragmatic randomised controlled patient-preference equivalence trial in primary care (EFFIMODI study).
Original language	Undefined/Unknown
Pages (from-to)	841-849
Number of pages	9
Journal	Diabetes, Obesity & Metabolism
Volume	16
Issue number	9
Publication status	Published - 2014

Access to Document

http://www.ncbi.nlm.nih.gov/pubmed/24635880

Cite this

Wermeling, P. R., Gorter, K. J., Stellato, R. K., de Wit, G. A., Beulens, J. W. J., & Rutten, G. E. H. M. (2014). Effectiveness and cost-effectiveness of 3-monthly versus 6-monthly monitoring of well-controlled type 2 diabetes patients: a pragmatic randomised controlled patient-preference equivalence trial in primary care (EFFIMODI study). Diabetes, Obesity & Metabolism, 16(9), 841-849. http://www.ncbi.nlm.nih.gov/pubmed/24635880

@article{80b6a400265c48d7b31dc8cdaec2c42e,

title = "Effectiveness and cost-effectiveness of 3-monthly versus 6-monthly monitoring of well-controlled type 2 diabetes patients: a pragmatic randomised controlled patient-preference equivalence trial in primary care (EFFIMODI study).",

author = "P.R. Wermeling and K.J. Gorter and R.K. Stellato and \{de Wit\}, G.A. and J.W.J. Beulens and G.E.H.M. Rutten",

year = "2014",

language = "Undefined/Unknown",

volume = "16",

pages = "841--849",

journal = "Diabetes, Obesity \& Metabolism",

issn = "1462-8902",

publisher = "John Wiley \& Sons Inc.",

number = "9",

}

Wermeling, PR, Gorter, KJ, Stellato, RK , de Wit, GA, Beulens, JWJ & Rutten, GEHM 2014, 'Effectiveness and cost-effectiveness of 3-monthly versus 6-monthly monitoring of well-controlled type 2 diabetes patients: a pragmatic randomised controlled patient-preference equivalence trial in primary care (EFFIMODI study).', Diabetes, Obesity & Metabolism, vol. 16, no. 9, pp. 841-849. <http://www.ncbi.nlm.nih.gov/pubmed/24635880>

Effectiveness and cost-effectiveness of 3-monthly versus 6-monthly monitoring of well-controlled type 2 diabetes patients: a pragmatic randomised controlled patient-preference equivalence trial in primary care (EFFIMODI study). / Wermeling, P.R.; Gorter, K.J.; Stellato, R.K. et al.
In: Diabetes, Obesity & Metabolism, Vol. 16, No. 9, 2014, p. 841-849.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Effectiveness and cost-effectiveness of 3-monthly versus 6-monthly monitoring of well-controlled type 2 diabetes patients: a pragmatic randomised controlled patient-preference equivalence trial in primary care (EFFIMODI study).

AU - Wermeling, P.R.

AU - Gorter, K.J.

AU - Stellato, R.K.

AU - de Wit, G.A.

AU - Beulens, J.W.J.

AU - Rutten, G.E.H.M.

PY - 2014

Y1 - 2014

M3 - Article

SN - 1462-8902

VL - 16

SP - 841

EP - 849

JO - Diabetes, Obesity & Metabolism

JF - Diabetes, Obesity & Metabolism

IS - 9

ER -